As our study shows, fetal stem cell treatment improved both subjective and objective breathing parameters as early as 6 months post‐treatment in patients wirh respiratory failure. A significant increase in the forced vital capacity and forced expiratory volume in 1 second was reported by all patients with grade Ⅰ respiratory failure linked to ALS and MD compared to baseline. Patient respiratory improvement was maintained over the next 6 months. Grade Ⅱ RF patients with MD reported a significant improvement in FVC 12 months after treatment.
Nataliia S. Sych, Olena V. Ivankova , Mariya O. Klunnyk, Iryna G. Matiyashchuk, Andrey A. Sinelnyk, Mariya P. Demchyk, Maryna V. Skalozyb, Dario Siniscalco. Fetal stem cells are effective in the treatment of Grade Ⅰ and Ⅱ respiratory failure in amyotrophic lateral sclerosis and muscular dystrophy. // Translational Neuroscience and Clinics. – September 2015. – No. 1 Vol. 1, pp. 10–16.